Objective: Although existing instruments contain items addressing the effect of ADHD medications on emotional expression, a review of measures did not yield any instruments that thoroughly evaluated positive and negative aspects of emotional expression. Method: The Expression and Emotion Scale for Children (EESC), a parent-report measure, was developed from an analysis of qualitative data from parent focus groups and expert opinion. Data from 179 parents and children treated with stimulants or atomoxetine are used to examine the psychometric properties of the EESC. Results: The EESC demonstrates good internal consistency and test-retest reliability. A factor analysis yields three factors (positive, flat, and emotional lability) that were consistent with the predicted structure of the measure. Small to moderate correlations between the EESC and psychological symptom measures are found, with the strength of the relationships varying by symptom measure. Conclusion: The EESC shows appropriate psychometric properties and is appropriate for use in clinical and research settings. (J. of Att. Dis. 2008; 11(5) 568-579)
Achenbach, T.M., & Rescorla, L.A. (2001). Manual for the ASEBA school-age forms and profiles. Burlington, VT: Research Center for Children, Youth, and Families.
2.
American Academy of Child and Adolescent Psychiatry. (2002). Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 26S-49S.
3.
American Academy of Pediatrics Committee on Quality Improvement, Subcommittee on Attention-Deficit/Hyperactivity Disorder. ( 2001). Clinical practice guideline: Treatment of the school-age child with attention-deficit/hyperactivity disorder. Pediatrics , 108, 1033-1044.
4.
American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author .
5.
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text revision). Washington, DC: Author.
6.
Bagwell, C.L., Molina, B.S., Pelham, W.E., & Hoza, B. (2001). Attention-deficit hyperactivity disorder and problems in peer relations: Predictions from childhood to adolescence. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 1285-1292.
7.
Biederman, J., Faraone, S.V., Monuteaux, M.C., & Grossbard, J.R. (2004). How informative are parent reports of attention-deficit/ hyperactivity disorder symptoms for assessing outcome in clinical trials of long-acting treatments? A pooled analysis of parents' and teachers' reports. Pediatrics, 113, 1667-1671.
8.
Biederman, J., Gao, H., Rogers, A.K., & Spencer, T.J. (2006). Comparison of parent and teacher reports of attention-deficit/ hyperactivity disorder symptoms from two placebo-controlled studies of atomoxetine in children. Biological Psychiatry, 60, 1106-1110.
9.
Buhrmester, D., Whalen, C.K., Henker, B., MacDonald, V., & Hinshaw, S.P. (1992). Prosocial behavior in hyperactive boys: Effects of stimulant medication and comparison with normal boys. Journal of Abnormal Child Psychology, 20, 103-121.
10.
Chan, E., Zhan, C., & Homer, C.J. (2002). Health care use and costs for children with attention-deficit/hyperactivity disorder: National estimates from the medical expenditure panel survey. Archives of Pediatric and Adolescent Medicine, 156, 504-511.
11.
Collett, B.R., Ohan, J.L., & Myers, K.M. (2003). Ten-year review of rating scales. V: Scales assessing attention deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 1015-1037.
Conners, C.K., March, J.S., Frances, A., Wells, K.C., & Ross, R. (2001). Treatment of attention-deficit/hyperactivity disorder: Expert consensus guidelines. Journal of Attention Disorders , 4, S7-S34.
14.
DeVillis, R.F. (1991). Scale development: Theory and applications. Thousand Oaks, CA: Sage.
15.
Doerfler, L.A., Felner, R.D., Rowlison, R.T., Raley. P. A., & Evans, E. (1988). Depression in children and adolescents: A comparative analysis of the utility and construct validity of two measures. Journal of Consulting and Clinical Psychology, 56, 769-772.
16.
Doherty, S.L., Frankenberger, W., & Fuhrer, R. (2000). Children's self-reported effects of stimulant medication. International Journal of Disability, Development and Education, 47, 39-54.
17.
Faraone, S.V., Biederman, J., Monuteaux, M.C., Doyle, A.E., & Seidman, L.J. (2001). A psychometric measure of learning disability predicts educational failure four years later in boys with attention-deficit/hyperactivity disorder. Journal of Attention Disorders, 4, 220-230.
18.
Granger, D.A., Whalen, C.K., & Henker, B. (1993). Perceptions of methylphenidate effects on hyperactive children's peer interactions. Journal of Abnormal Child Psychology , 21, 535-549.
19.
Greene, R.W., Biederman, J., Faraone, S.V., Monuteaux, M.C., Mick, E., DuPre, E.P., et al. (2001). Social impairment in girls with ADHD: Patterns, gender comparisons, and correlates. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 704-710.
20.
Greenhill, L., Pliszka, S., Dulcan, M.K., Bernet, W., Arnold, V., Beitchman, J., et al. (2002). Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 26S-49S.
21.
Guevara, J., Lozano, P., Wickizer, T., Mell, L., & Gephart, H. (2001). Utilization and cost of health care services for children with attention-deficit/hyperactivity disorder. Pediatrics , 108, 71-78.
22.
Harrison, C., & Sofronoff, K. (2002). ADHD and parental psychological distress: Role of demographics, child behavioral characteristics, and parental cognitions . Journal of the American Academy of Child and Adolescent Psychiatry, 41, 703-711.
23.
Johnson, J.H., & Reader, S.K. (2002). Assessing stress in families of children with ADHD: Preliminary development of the Disruptive Behavior Stress Inventory (DBSI). Journal of Clinical Psychology in Medical Settings , 9, 51-62.
24.
Johnston, C., & Mash, E.J. (2001). Families of children with attention-deficit/hyperactivity disorder: Review and recommendations for future research. Clinical Child and Family Psychology Review, 4, 183-207.
25.
Knight, D., Hensley, V.R., & Waters, B. (1988). Validation of the Children's Depression Scale and the Children's Depression Inventory in a prepubertal sample. Journal of Child Psychology Psychiatry and Allied Disciplines, 29, 853-863.
26.
Kovacs, M. (1992). Children's Depression Inventory (CDI) manual. North Tonawanda, NY: Multi-Health Systems.
27.
Kratochvil, C.J., Faries, D., Vaughan, B., Perwien, A.R., Busner, J., Saylor, K., et al. (2004, October). Emotional expression during ADHD treatment: Initial assessment of treatment effects. Poster session presented at the annual meeting of the American Academy of Child and Adolescent Psychiatry, Toronto, Ontario, Canada.
28.
Kratochvil, C.J., Vaughan, B.S., Harrington, M.J., & Burke, W.J. (2003). Atomoxetine: A selective nonadrenaline reuptake inhibitor for the treatment of attention-deficit/hyperactivity disorder. Expert Opinion on Pharmacotherapy, 4, 1165-1174.
29.
Leibson, C.L., Katusic, S.K., Barbaresi, W.J., Ranson, J., & O'Brien, P.C. (2001). Use and costs of medical care for children and adolescents with and without attention-deficit/hyperactivity disorder. Journal of the American Medical Association, 285, 53-66.
30.
Lessler, J.T., & Forsyth, B.H. (1996). A coding system for appraising questionnaires . In N. Schwarz & S. Sudman (Eds.), Answering questions: Methodology for determining cognitive and communicative process in survey research (pp. 259-292). San Francisco: Jossey-Bass.
31.
March, J.S., Parker, J.D., Sullivan, K., Stallings, P., & Conners, C.K. (1997). The Multidimensional Anxiety Scale for Children (MASC): Factor structure, reliability, and validity. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 554-565.
32.
March, J.S., & Sullivan, K. (1999). Test-retest reliability of the Multidimensional Anxiety Scale for Children. Journal of Anxiety Disorders, 13, 349-358.
33.
Michelson, D., Faries, D., Wernicke, J., Kelsey, D., Kendrick, K., Sallee, F.R., et al. (2001). Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: A randomized, placebo-controlled, dose-response study. Pediatrics, 108, e83.
34.
Mitsis, E.M., McKay, K.E., Schulz, K.P., Newcorn, J.H., & Halperin, J.M. (2000). Parent-teacher concordance for DSM-IV attention-deficit/hyperactivity disorder in a clinic-referred sample . Journal of the American Academy of Child and Adolescent Psychiatry, 39, 308-313.
35.
MTA Cooperative Group. (1999). A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Archives of General Psychiatry, 56, 1073-1086.
36.
Pastor, P.N., & Reuben, C.A. (2002). Attention deficit disorder and learning disability: United States, 1997-1998. Vital Health Statistics, 10, 1-11.
37.
Pelham, W.E., Milich, R., Murphy, D.S., & Murphy, H. (1989). Normative data on the IOWA Conners Teacher Rating Scale. Journal of Clinical Child and Adolescent Psychology , 18, 259-262.
38.
Pelham, W.E., Wheeler, T., & Chronis, A. (1998). Empirically supported psychosocial treatments for attention deficit hyperactivity disorder. Journal of Clinical Child and Adolescent Psychology, 27, 190-205.
39.
Perwien, A.R., Faries, D.E., Kratochvil, C.J., Sumner, C.R., Kelsey, D.K., & Allen, A.J. (2004). Improvement in health-related quality of life in children with ADHD: An analysis of placebo controlled studies of atomoxetine . Journal of Developmental and Behavioral Pediatrics, 25, 265-271.
40.
Reich, W. (2000). Diagnostic Interview for Children and Adolescents (DICA). Journal of the American Academy of Child and Adolescent Psychiatry, 39, 59-66.
41.
Rowe, K., & Rowe, K. (1997). Norms for parental ratings on Conners' Abbreviated Parent-Teacher Questionnaire: Implications for the design of behavioral rating inventories and analyses of data derived from them. Journal of Abnormal Child Psychology, 25, 425-451.
42.
Sawyer, M.G., Whaites, L., Rey, J.M., Hazell, P.L., Graetz, B., & Baghurst, P. (2002). Health-related quality of life of children and adolescents with mental disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 530-537.
43.
Saylor, K.E., Buermeyer, C.M., Spencer, T.J., & Barkley, R.A. (2002). Adaptive changes related to medication treatment of ADHD: Listening to parents of children in clinical trials of a novel nonstimulant medication. Journal ofClinical Psychiatry, 63, 23-28.
44.
Sprague, R.L., & Sleator, E.K. (1973). Effects of psychopharmacological agents on learning disorders. Pediatric Clinics of North America, 20, 719-735.
45.
Thurber, J.R., Heller, T.L., & Hinshaw, S.P. (2002). The social behaviors and peer expectation of girls with attention deficit hyperactivity disorder and comparison girls. Journal of Clinical Child and Adolescent Psychiatry, 31, 443-452.
46.
Whalen, C.K., Henker, B., & Granger, D.A. (1989). Ratings of medication effects in hyperactive children: Viable or vulnerable? Behavior Assessment, 11, 179-199.
47.
Whalen, C.K., Henker, B., Jamner, L.D., Ishikawa, S.S., Floro, J.N., Swindle, R., et al. (2006). Toward mapping daily challenges of living with ADHD: Maternal and child perspectives using electronic diaries. Journal of Abnormal Child Psychology, 34, 1-16.
48.
Wolraich, M.L., Lambert, E.W., Bickman, L., Simmons, T., Doffing, M.A., & Worley, K.A. (2004). Assessing the impact of parent and teacher agreement on diagnosing attention-deficit hyperactivity disorder. Journal of Developmental and Behavioral Pediatrics, 25, 41-47.
